File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41598-024-65764-0
- Find via

Supplementary
-
Citations:
- Appears in Collections:
Article: The association between baseline viral load and long-term risk in patients with COVID-19 in Hong Kong: a territory-wide study
| Title | The association between baseline viral load and long-term risk in patients with COVID-19 in Hong Kong: a territory-wide study |
|---|---|
| Authors | |
| Issue Date | 28-Dec-2024 |
| Publisher | Springer Nature |
| Citation | Scientific Reports, 2024, v. 14 How to Cite? |
| Abstract | COVID-19 can increase the long-term risk of multiorgan dysfunction. Few studies investigated the long-term risk in Asian populations or investigated the association between viral load and long-term risk. We aimed to investigate the post-discharge rates of hospitalization and association with baseline viral load in all patients with COVID-19 in Hong Kong. This was a population-based cohort study included all patients with a positive RT-PCR test for SARS-CoV-2 in Hong Kong between January 1st 2020 and August 30th 2020, routinely admitted to public health care facilities for isolation and treatment. Viral Ct values were available in 3433 (85%) of patients. Outcomes of interest included death, cause-specific hospitalizations, and initiation of medication from the Hospital Authority's territory-wide electronic health records from the Clinical Data Analysis and Reporting System. In total, 4054 people in Hong Kong tested positive for COVID-19 and were admitted to a public health care facility, of whom 167 (4.1%) were admitted to ICU. During a median follow-up time of 251 (interquartile range 240-279) days, 408 (11.9%) were hospitalized for any reason and 16 (0.5%) patients died. After discharge, patients were most often readmitted for respiratory reasons, followed by gastro-intestinal reasons. A higher viral load (lower RT-PCR Ct values) was associated with a higher likelihood of death (Hazard ratio [HR] 5.86, 95% Confidence interval [CI] 2.57-13.33), hospitalization (HR 1.22, 95%CI 1.08-1.39) or hospitalization for cardiovascular disease (HR 12.78, 95%CI 3.67-44.48). Patients with higher viral loads more likely started ACE-inhibitors (HR 1.37, 95%CI 1.12-1.68) and non-opioid analgesics (HR 1.01, 95%CI 1.01-1.23). In a relatively mild COVID-19 population from Hong Kong, the post-acute risk of complications was substantial. Our results highlight that higher viral load predict post-acute complications in patients with relatively mild disease. |
| Persistent Identifier | http://hdl.handle.net/10722/366597 |
| ISSN | 2023 Impact Factor: 3.8 2023 SCImago Journal Rankings: 0.900 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tromp, Jasper | - |
| dc.contributor.author | Wong, Michael | - |
| dc.contributor.author | Ouwerkerk, Wouter | - |
| dc.contributor.author | Wu, Mei-Zhen | - |
| dc.contributor.author | Ren, Qing-wen | - |
| dc.contributor.author | Chandramouli, Chanchal | - |
| dc.contributor.author | Teramoto, Kanako | - |
| dc.contributor.author | Teng, Katherine Tiew-Hwa | - |
| dc.contributor.author | Huang, Jiayi | - |
| dc.contributor.author | To, Kelvin-Kai-Wang | - |
| dc.contributor.author | Hung, Ivan-Fan-Ngai | - |
| dc.contributor.author | Tse, Hung-Fat | - |
| dc.contributor.author | Lam, Carolyn S P | - |
| dc.contributor.author | Yiu, Kai Hang | - |
| dc.date.accessioned | 2025-11-25T04:20:22Z | - |
| dc.date.available | 2025-11-25T04:20:22Z | - |
| dc.date.issued | 2024-12-28 | - |
| dc.identifier.citation | Scientific Reports, 2024, v. 14 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/366597 | - |
| dc.description.abstract | <p>COVID-19 can increase the long-term risk of multiorgan dysfunction. Few studies investigated the long-term risk in Asian populations or investigated the association between viral load and long-term risk. We aimed to investigate the post-discharge rates of hospitalization and association with baseline viral load in all patients with COVID-19 in Hong Kong. This was a population-based cohort study included all patients with a positive RT-PCR test for SARS-CoV-2 in Hong Kong between January 1st 2020 and August 30th 2020, routinely admitted to public health care facilities for isolation and treatment. Viral Ct values were available in 3433 (85%) of patients. Outcomes of interest included death, cause-specific hospitalizations, and initiation of medication from the Hospital Authority's territory-wide electronic health records from the Clinical Data Analysis and Reporting System. In total, 4054 people in Hong Kong tested positive for COVID-19 and were admitted to a public health care facility, of whom 167 (4.1%) were admitted to ICU. During a median follow-up time of 251 (interquartile range 240-279) days, 408 (11.9%) were hospitalized for any reason and 16 (0.5%) patients died. After discharge, patients were most often readmitted for respiratory reasons, followed by gastro-intestinal reasons. A higher viral load (lower RT-PCR Ct values) was associated with a higher likelihood of death (Hazard ratio [HR] 5.86, 95% Confidence interval [CI] 2.57-13.33), hospitalization (HR 1.22, 95%CI 1.08-1.39) or hospitalization for cardiovascular disease (HR 12.78, 95%CI 3.67-44.48). Patients with higher viral loads more likely started ACE-inhibitors (HR 1.37, 95%CI 1.12-1.68) and non-opioid analgesics (HR 1.01, 95%CI 1.01-1.23). In a relatively mild COVID-19 population from Hong Kong, the post-acute risk of complications was substantial. Our results highlight that higher viral load predict post-acute complications in patients with relatively mild disease.<br></p> | - |
| dc.language | eng | - |
| dc.publisher | Springer Nature | - |
| dc.relation.ispartof | Scientific Reports | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.title | The association between baseline viral load and long-term risk in patients with COVID-19 in Hong Kong: a territory-wide study | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1038/s41598-024-65764-0 | - |
| dc.identifier.volume | 14 | - |
| dc.identifier.eissn | 2045-2322 | - |
| dc.identifier.issnl | 2045-2322 | - |
